Member Info for Skippysb01

What we have is something that positively contributes to keeping the NHS and perhaps some areas of the economy (obvious one is air travel) open. Nobody wants another lockdown but I would like to have more confidence that the NHS won't get overrun and that if I have to go somewhere it is as safe as it can be.

Amagedon21 - You are correct that we were expecting this 'longitudinal study' last year. BRH haven't been great at understanding how to get product to market IMHO. I don't think that means they won't get there.

Dickpuller -not sure how this RNS would increase the SP today. It's forward looking and says to me - we may have good news in about 10-14 weeks time (2 weeks to start the trial + 1 month recruitment + 1 month review and of course there is the longitudinal part.

The fate of the SP for the rest of the year is tied to how Covid behaves in the Autumn Winter and what the trial shows.

I mentioned timing recently. IF this test gets visible approval as something that can really help the NHS frontline by being fast and accurate for staff and patients then we have potential running into winter.

I have to say that anecdotally Covid is having a big impact on the workforce at my work. We have a signifiant number of people off with it at any one time and perhaps more seriously we have staff with hospital appointments being postponed several times because NHS staff have Covid and they can't cope. This is the market.

Not sure it wouldn't get a pass from the regulator TBH. They were allowed to takeover Friends Life 7 years ago.

Aviva sale of overseas business recently and strategic focus on UK. I would expect some M&A activity in the short to medium term.

Could our Covid test trial actually be quite well timed? Risking covid cases in the news again and big impact on hospital staffing and complexity of treating at risk patients in pandemic. We have a test that is ideal for hospital/GP setting.

Results in next few weeks?

I can't imagine that Trevor will be selling right now. Unless he wants to go to prison.

Very close on 2 of the resolutions but yes all passed.

Interestingly enough, the 2 small share buys by Trev over the last few weeks were probably enough to swing it in his favour.

Yozzer and all. Think about this. What do you honk would happen if BRH preempted that they were going to buy into something before they did it? What happens to the value of that investment BEFORE BRH invest in it?

Nobody does that. It don’t just BRH.

Now now. Calling me a Bojo supported is far off the pitch. That ball just fell on Mars.

However - it's cool to be angry about it. BUT - the nature of this investment has been clear for a long long time. So what do you do?

Moaning about it isn't going to get the SP up. Ultimately this risk/return bet we all had isn't straight forward. I prefer the BOD to have flexibility to invest and that was somewhat hampered by shareholders recently. For me it's not about how much money I have lost it's about whether I get it back with a profit. I can afford to lose my investment hear and yes it will P me off but I get that this is an eventuality that can occur.

However investing in AIM does this. TB is the 'bad guy' here but AIM investors have lost far more on other bets. Check out SNG, DDD, EUA, many many others. They didnt have a TB tp poke at but the outcome is not good right now.

Now I bet you for each of those companies plenty of AIM investors will tell me that they are going to take off - and maybe they will and I hope they do. Same here.

Amagedon21 - I actually think the BRH BOD is not bad at telling us what's going on compared to other AIM companies. I know what's happening, what's going well, what's in progress. etc. If I consider that they cannot disclose outside of RNS I'm not sure we are missing much at all.

I meant BRH not NRH obvs..

Seems to me that TB is accumulating some BRH shares at below 12p. Not many but then not too many opportunities to do that. He's not buying them because he expect the SP to fall now is he....

TB also bought a million Chamberlin & Hill shares last week.

He's an investor. I recall the RNS that stated that BRH saw opportunity in the current market for recovery shares - which investors were not happy about allowing the board the freedom to invest in.

I honestly think the biggest problem for NRH right now is the shareholders.

666 trade just gone through.... just saying

It was 7p last week. No way a speeding ticket coming.

The truth is that if there was even a smidgen of de escalation in the Ukraine war - this stock will bag. So it's an obvious punt if you can stomach losing it.

From RNS - 'We also recently welcomed KPMG on board as agent within Russia to progress our asset sale strategy.'

KPMG are multi faceted and provide expertise in all areas of business. So in this case it really is specifically to assist with progressing the sale strategy as described in the RNS.

You bring big 4 consultancy to help with stuff you don't have the expertise/required skills for in house or because you want a separate line of expert opinion.

They have not completed the trial. I spoke to BRH and we can expect an update in the coming weeks but the trial likely only just started. That RNS is older news. In more recent updates they haven't stated done by end June but did state they had the go ahead from NIH in the results RNS.

If the trial finished end June then it can take weeks to study the data before releasing results.

The people suggesting he had left did not believe he had left - they were just trying to sow doubt and cause trouble.

Moz2020 - Closed period was for financial reporting.

No closed period for any future undisclosed news.

An insider is not supposed to buy or sell shares if they know of material (as yet undisclosed to the market) information that could impact the share price. In my view TB bought a few this week at the start of the Covid trial as the outcome is not known. This is 'insider sentiment' rather than 'insider dealing'. i.e. he has confidence in the outcome rather than knows the outcome.

It's a minefield because a director surely knows a lot more about the likely direction of the company than a shareholder.

What update are we expecting at end of June?